Process for preparing 2,2-difluoroethylamine
View Patent ↗The present invention relates to a process for preparing 2,2-difluoroethylamine proceeding from 2,2-difluoro-1-haloethane using ammonia in a solvent which has a maximum water content of 15% by volume and in the presence of a catalyst which accelerates the reaction with ammonia.
1. Process for preparing 2,2-difluoroethylamine, wherein said process comprises
reacting 2,2-difluoro-1-haloethane having the general formula (I):
CHF 2 —CH 2 Hal (I),
where Hal is chlorine, bromine, or iodine
with ammonia in a solvent which has a maximum water content of 15% by volume and in the presence of a catalyst which accelerates the reacting of 2,2-difluoro-1-haloethane with ammonia.
2. Process according to claim 1 , wherein the molar ratio of 2,2-difluoro-1-haloethane to the ammonia used is in the range from 0.8:1 to 1:30.
3. Process according to claim 1 , wherein the solvent is selected from methanol, ethanol, isopropanol, butanol, 2-(2-ethoxyethoxy)ethanol, diethylene glycol, ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenetole, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethylglycol, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropylethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, dioxane, and polyethers of ethylene oxide and/or propylene oxide, hexamethylenephosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropylformamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methylcaprolactam, 1,3-dimethyl-3,4,5,6-tetrahydro-2 (1H)-pyrimidine, octylpyrrolidone, octylcaprolactam, 1,3-dimethyl-2-imidazolindione, N-formylpiperidine, N,N′-1,4-diformylpiperazine and dimethyl sulphoxide.
4. Process according to claim 1 , wherein the catalyst is formed in situ.
5. Process according to claim 1 , wherein the catalyst is selected from potassium bromide, sodium iodide, potassium iodide and tetrabutylammonium bromide.
6. Process according to claim 2 , wherein the solvent is selected from methanol, ethanol, isopropanol, butanol, 2-(2-ethoxyethoxy)ethanol, diethylene glycol, ethyl propyl ether, methyl tert-butyl ether, n-butyl ether, anisole, phenetole, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethylglycol, diphenyl ether, dipropyl ether, diisopropyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, isopropylethyl ether, diethylene glycol dimethyl ether, triethylene glycol dimethyl ether, tetrahydrofuran, dioxane, and polyethers of ethylene oxide and/or propylene oxide, hexamethylenephosphoramide, formamide, N,N-dimethylacetamide, N-methylformamide, N,N-dimethylformamide, N,N-dipropyl-formamide, N,N-dibutylformamide, N-methylpyrrolidine, N-methylcaprolactam, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidine, octylpyrrolidone, octylcaprolactam, 1,3-dimethyl-2-imidazolindione, N-formylpiperidine, N,N′-1,4-diformylpiperazine and dimethyl sulphoxide.
7. Process according to claim 2 , wherein the catalyst is formed in situ.
8. Process according to claim 2 , wherein the catalyst is selected from potassium bromide, sodium iodide, potassium iodide and tetrabutylammonium bromide.